John Palma

Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA.

Stemina Biomarker Discovery, Inc. engages in the development and commercialization of molecular biomarkers to improve drug safety and human health. Its products and services include Cardio quickPredict, devTOX quickPredict, and TOXquickPredict. The company was founded by Elizabeth L. R. Donley and Gabriela G. Cezar in November 2006 and is headquartered in Madison, WI.

YourBio Health, Inc. develops health monitoring products. It is developing an array of products based on the company's proprietary TAP? (Touch Activated Phlebotomy) painless blood collection platform. The company was founded by Richard Rox Anderson, Joerg Lahann, Robert S. Langer Jr., Douglas A. Levinson and Samir Mitragotri in 2008 and is headquartered in Medford, MA.

Iquity Systems AB is a Swedish company that specializes in accelerating precision medicine. The private company is based in Stockholm, Sweden. The company's focus is on delivering the right patient with the right drug at the right time. The company was founded by Chase Spurlock and he has been the CEO since incorporation.

OnTarget, Inc. provides consulting services and training program for sales and consulting firm. The company is headquartered in Atlanta, GA.

Picomole Instruments, Inc. develops patented technologies for breath test for lung cancer screening. Its products include breath sampler and breath analyzer. The company was founded by John Cormier and is headquartered in Moncton, Canada.

Part of Bioporto A/S, Bioporto Diagnostics A/S is a Danish company that engages in research and experimental development on biotechnology. The private company is based in Gentofte, Denmark. Peter Morch Eriksen has been the CEO of the company since 2013.

Geneoscopy LLC develops diagnostics It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. The firm provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. The company was founded by Andrew Barnell, Erica Barnell and Yiming Kang in 2015 and is headquartered in Saint Louis, MO.

Iquity, Inc. is an American company that focuses on accelerating precision medicine. Iquity is based in Nashville. The private company's goal is to deliver the promise of precision medicine by ensuring that the right patient receives the right drug at the right time. The company recognizes that precision medicine is a complex process that requires connected data, mature, scalable data operations, and analytics expertise.

Decode Health, Inc. is an American US-based health-tech company that provides a data platform to accelerate precision medicine and improve the efficiency of pharma research and development using AI and machine learning. The private company has partnered with leading research partners, diagnostic and technology companies to support pharma R & D. The company's goal is to deliver on the promise of precision medicine by connecting data and providing mature, scalable data operations and analytics expertise.

Good Start Genetics, Inc. operates as a molecular diagnostics firm. It offers pre-pregnancy diagnostic test services to screen a panel of genetic disorders. The firm also provides clinical laboratory and genetic counseling support services. The company was founded by Eric Boutin, Paris Wallace, and Gregory J. Porreca in December 2007 and is headquartered in Cambridge, MA.